InvestorsHub Logo
Followers 46
Posts 4453
Boards Moderated 0
Alias Born 07/26/2010

Re: RNsidersbuying post# 788

Saturday, 09/19/2020 1:20:26 PM

Saturday, September 19, 2020 1:20:26 PM

Post# of 2791
July 28, 2020 - "This collaboration will determine if Pritumumab can effectively block SARS2 in an animal mouse model. It will also gauge Pritumumab's ability to bind vimentin in a live model."

https://finance.yahoo.com/news/nascent-biotech-announces-collaboration-syracuse-120000355.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NBIO News